| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/22/2026 | ±3.0% | -2.6% | over-priced |
| 07/23/2026 | ±3.5% | -1.1% | over-priced |
| 04/23/2026 | ±3.5% | -0.7% | over-priced |
| 02/19/2026 | ±5.2% | +0.6% | over-priced |
| 10/23/2025 | ±7.3% | +2.2% | over-priced |
| 07/24/2025 | ±2.8% | +0.1% | over-priced |
| 04/24/2025 | ±4.3% | +4.8% | under-priced |
| 02/21/2025 | ±2.4% | -5.7% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $2.35 | $6.4B | $2.5B |
| Q2 FY2026 | $2.06 | $6.1B | $2.2B |
| Q1 FY2026 | $3.00 | $7.3B | $3.3B |
| Q4 FY2025 | — | $6.8B | $1.3B |
NEM (NEM) reports in 86 days, with the next report estimated for 01/21/2027. Across the last 8 reports, options priced an average ±4.0% earnings move while the stock actually moved 2.2% on average — the market has systematically over-priced NEM's earnings risk. Fundamentals into the print: EPS up 40.7% year-over-year, revenue up 15.2%. QuantLogix's live 5-factor engine currently reads NEM as a buy at 63/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →